Joshua Rosenblat, MD, MSc, FRCPC
@JD_Rosenblat
Followers
3K
Following
5K
Media
207
Statuses
2K
Psychiatrist & Researcher @UHN @UofTPsych | Views my own and not medical advice
Toronto
Joined June 2020
Canada's FIRST #psilcoybin clinical trial:. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. @MedCellPress @UofTPsych @UofT . 50day #free full text: . Thread - 1/5.
33
61
192
RT @realJoshSiegel: What went wrong with MDMA for PTSD at the FDA? . Was the recent Phase 3 COMPASS trial a breakthrough or a letdown? . Sh….
0
5
0
RT @rogersmcintyre: This survey reports that 85% of academics studying psychedelics report their own personal experience with psychedelics….
pubmed.ncbi.nlm.nih.gov
The findings highlight the prevalence of personal psychedelic experiences among this sample of researchers and their influence on research interests and opinions. The results underscore the need for...
0
12
0
RT @Pignatelli_Lab: Excellent write-up on some of our recent findings. @BBRFoundation . Researchers Trace How Ketamine Acts on Specific Bra….
bbrfoundation.org
Researchers have published a highly detailed account of a mechanism through which ketamine, a rapid-acting antidepressant, alters plasticity, or the strength of connections between neurons, and in so...
0
9
0
RT @JAMAPsych: Viewpoint: Ketamine's antidepressant potential is hindered by commercial barriers, highlighting the need for a federal progr….
0
45
0
RT @ScienceMagazine: 🎉 Congratulations to Newton Cho, the 2025 winner of the Science & PINS Prize for Neuromodulation for his work identify….
0
48
0
RT @LukeJelen: 1/ Just out in @NatureMedicine : we show the opioid system modulates ketamine’s effects in major depressive disorder, with n….
nature.com
Nature Medicine - The opioid system modulates ketamine’s effects in major depressive disorder, with naltrexone reducing acute glutamatergic activity and acute antidepressant effects.
0
44
0
RT @rogersmcintyre: Esketamine and ketamine associate with lower reporting most aspects of suicidality to the WHO Pharmacovigilance databas….
pubmed.ncbi.nlm.nih.gov
Background: Ketamine and esketamine have been reported to rapidly alleviate various parameters of suicidality, with antisuicidal effects that may be independent of their rapid-acting antidepressant...
0
6
0
RT @JAMAPsych: Systematic review and meta-analysis: Stopping antidepressants leads to slight symptom increases compared to placebo, but the….
0
69
0
RT @CRodriguezMDPhD: Single-dose (10 mg) psilocybin reduces symptoms in adults with OCD: A pharmacological challenge study:..
0
13
0
RT @JAMAPsych: Esketamine nasal spray as a monotherapy improved depressive symptoms in treatment-resistant depression (TRD) compared to pla….
0
34
0
RT @flobrand: Great news and yet another significant step forward for psychedelic medicine!. Today, @atai_life and @BeckleyPsytech announc….
0
23
0
RT @MichaelHaichin: “Approval rates significantly declined from 2022 to 2024 [. ] In 2022, 74 of the 90 (82%) requests were approved, foll….
0
2
0
RT @CAMHnews: UHN and CAMH are bridging the gap between physical and mental health care. The partnership marks a transformation in integra….
0
10
0
RT @UofTPsych: Exploring everything from the impact of mitochondrial DNA variants on the risk for schizophrenia to mystical experiences as….
0
3
0
RT @JAMAPsych: Viewpoint explores potential justifications underlying the @US_FDA rejection of methylenedioxymethamphetamine (MDMA) as a tr….
0
12
0
RT @BellevueDoc: Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Scre….
journals.sagepub.com
Objective To compare changes in depression, anxiety, and suicidality symptoms after a single 25 mg oral dose of psilocybin between treatment-resistant depressio...
0
7
0
RT @SalahpourAli: We have a new Faculty position available in our Dept. Please share and repost.
jobs.utoronto.ca
Assistant Professor - Pharmacology & Toxicology
0
9
0
RT @BellevueDoc: Efficacy and safety of low-versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial. h….
cell.com
This randomized, double-blind trial evaluated the efficacy of lysergic acid diethylamide (LSD)-assisted therapy in patients with moderate-to-severe major depressive disorder. Results showed greater...
0
6
0
RT @DrNirLipsman: Hard to believe it’s been 5 years since we lost Todd Mainprize. An incredible surgeon, teacher, father, husband and frien….
0
4
0
RT @APAPubJournals: An overview describes anhedonia’s significance as both a symptom and diagnostic marker, prevalence, and pathophysiologi….
0
2
0